Introduction
============

Seventy years ago, Randall examined the papillae of cadaveric renal units and demonstrated that interstitial crystal plaques in the papillary tip were common in stone formers ([@b24]). These crystals were composed not of calcium oxalate (CaOx), the most common solid phase found in patients with nephrolithiasis, but of calcium phosphate (CaP). He believed that the CaP crystals serve as a nucleation surface for CaOx ([@b25]). In vitro, CaP phases efficiently nucleate CaOx crystallization ([@b19]), so that one can easily conjecture that common CaOx stones begin on plaques. Recently, [@b20] analyzed RP and confirmed that they are formed of spherical CaP deposits with a multilaminated internal morphology ([Figures 1A, B](#fig1){ref-type="fig"}). According to the Merck Manual (2006), all pathological calcifications contain snowball-like CaP spheres 200 nm in size. However, the identity of those spherical formations has remained elusive.

![Morphological similarities of published TEM images of spherical, apatite-containing formations in renal papillae (**A** and **B**) and CNP (**C** and **D**). Magnifications: **A**, 20,000X; **B**, 30,000X; **C** and **D**, bars 200 nm. Reprinted from **A**: Coe FL, Evan A, Worcester E. 2005. Kidney stone disease. *J Clin Invest*, 115:2598--2608, with permission from American Urological Association. **B**: Matlaga BR, Coe FL, Evan AP, et al 2007. The role of Randall's plaques in the pathogenesis of calcium stones. *J Urol*, 177:31--38, with permission from American Urological Association. **C**: Kajander EO, Ciftcioglu N. 1998. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. *Proc Natl Acad Sci USA*, 95:8274--8279, with permission from National Academy of Sciences USA. **D**: Kajander EO, Ciftcioglu N, Aho K, et al 2003. Characteristics of nanobacteria and their possible role in stone formation. *Urol Res,* 31:47--54, with kind permission from Springer Science and Business Media.](ijn0301-105-01){#fig1}

Structures similar to the snowballs were discovered over a decade ago in blood and blood products ([@b14]). These structures, CNP, were detected in numerous pathological calcifications, such as in kidney stones ([@b7]; [@b16]), in atherosclerotic plaques ([@b22]; [@b23]), in psammoma bodies of cancer ([@b13]), in prostatic stones ([@b28]), and in gallbladder ([@b32]). CNP are calcified ([@b14]), self-propagating ([@b5]) entities, morphologically very similar in mineral composition to spherical bodies observed in RP ([Figure 1A-D](#fig1){ref-type="fig"}). Due to lack of their genomic evidence, CNP are controversial agents as prions were, and critics have proposed hypotheses explaining them as precipitates of proteins or crystals ([@b8]). Although CNP cause specific infection ([@b6]), and are detected in pathological calcification, general debate over their existence continues. Methods to detect CNP include immuno-detection techniques using anti-CNP mAbs, culture-techniques and electron microscopy ([@b21]). With these methodologies, important features of CNP and their triggering effect on nephrolithiasis have been suggested: A) CNP consist of tiny, "cell-like" spheres (80--200 nm). They precipitate apatite from media forming apatite-protein complexes on their exterior membrane. This protein-associated mineralization ([@b31]) can reach a diameter of one to several micrometers ([@b17]; [@b2]). B) 14% of healthy adults in Scandinavia have anti-CNP antibodies ([@b12]). In comparison, 75% of patients with kidney diseases have CNP antigen in blood ([@b11]). C) CNP form apatite units/shells in vitro, morphologically and chemically similar to those in the core of kidney stones, ([Figure 2](#fig2){ref-type="fig"}) ([@b7]). D) CNP are renotropic ([@b1]). E) CNP cause renal stones when injected into rats ([@b10]). F) CNP have been detected in kidney stones ([@b7]). G) In vitro, destruction of the calcified apatite shell of CNP with EDTA-chelation reveals numerous 50 to 100 nm diameter membranous cells ([@b17]) similar to those observed in Randall plaques by other research groups ([@b20]). H) TEM study of renal plaques shows 1--5 μm apatite spheres, similar to the structure of CNP ([Figure 1](#fig1){ref-type="fig"}) ([@b14]; [@b20]).

![SEM images showing the similarity of apatite spheres in various sizes in the core of an oxalate kidney stone (**A**) and apatite formations in the CNP culture (**B**). Bars = A; 1 μm, B; 10 μm.](ijn0301-105-02){#fig2}

In this study, our aim was to investigate the association between the presence of CaP spheres found in RP and detection of CNP. Such an association would be a basis for a formal hypothesis that can be discussed, and used to drive further studies in larger patient groups.

Materials and methods
=====================

Subjects
--------

Renal papillae were dissected from 17 patients who had undergone laparoscopic nephrectomy due to neoplasia (renal cell carcinoma, n = 9; transitional cell carcinoma, n = 4; Other malignancies; n = 4). Presence or absence of RP was evaluated on gross inspection of immediately extracted and bivalved kidneys. Intact papillae were harvested well away from the tumor, and were prepared for the analyses with IHS, SEM, EDS and CNP culture. Blood was drawn from fasting patients before and after surgery. The serum was used for CNP culture and ELISA to detect CNP antigen and antibody. Bladder urine samples of patients were collected for routine bacterial culture. The study was approved by the UCSF Committee on Human Research and committee patient confidentiality and informed consent protocols were followed.

Tissue preparation for analysis
-------------------------------

Papillary specimens of 17 patients for IHS and SEM experiments were immersed in 4% paraformaldehyde and refrigerated overnight. IHS samples were paraffin embedded and prepared for IHS as described earlier ([@b26]). SEM samples were dehydrated and gold-coated as described previously ([@b20]). The tissue samples for CNP cultures were placed into 2 ml of sterile phosphate buffered saline (PBS), pH 7.4, homogenized for 30-seconds, four times, with 30-second cooling intervals on ice using conventional glass tissue-grinders. Homogenized tissue was centrifuged at 2500 g for 15-minutes. The supernatant was separated and sterile-filtered through 0.22 μm pore size, nonprotein binding filters (Millipore) into sterile nonadhesive tubes and stored at −70 °C until processed for culture as described below.

IHS analysis of papillary samples
---------------------------------

Paraffin-embedded papillary samples were cut into 5 μm sections, deparaffinized and rehydrated ([@b26]). Each tissue section was demineralized in 250 mM sodium citrate for 24-hours at +4 °C, to retrieve apatite crystal-covered epitopes prior to IHS. After washing in water, endogenous peroxidase was blocked with 1% H~2~O~2~ in methanol for 30-minutes. Slides were rinsed in PBS before staining with a catalyzed-signal-amplification IHS (Dako, Carpinteria, CA, USA). Anti-CNP mAb, 8D10 (Nanobac Oy, Kuopio, Finland), was used as primary antibody and counterstained with hematoxylin. Negative control sections went through the same staining process, except that the primary mAb step was omitted.

CNP cultures from serum and tissue samples
------------------------------------------

The samples were cultured in Dulbecco's Modified Eagle's Medium (DMEM, Gibco Lab Inc., Grand Island, NY) under cell culture conditions (37 °C, 5%--10% CO~2~, 90%--95% humidity) for 4 weeks. Patient sera were cultured at 10% final concentration, and tissue homogenates were cultured both with and without fetal bovine serum (FBS) supplementation which previously tested negative for CNP (Atlanta Biologicals, GA) as described earlier ([@b21]). The homogenized tissue pellets were incubated with 30 mM EDTA for 1-hour at room temperature for decalcification, diluted 1:10 in DMEM, and cultured as described above. To eliminate potential conventional-bacterial contamination, each sample was filtered through 0.22 μm pore-sized filters before culturing. Cultures were checked for gross bacterial contamination by microscopy and macroscopic observation of turbidity and medium color change from the third day of incubation. Controls containing only culture media were incubated in parallel with the test cultures to determine whether spontaneous precipitation can occur. Every week, cultures were inspected by phase contrast microscopy (Nikon Eclipse TE 2000-U) for CNP propagation. Positive identification of CNP involved typical slow propagation and optical properties, negative signal with Hoechst 33258 dye, and positive signal with indirect immunofluorescence staining (IIFS) ([@b5]). Serum and tissue homogenate cultures for CNP were rated (+) = growth in four weeks, (++) = in three weeks, (+++) = in two weeks, and (++++) = in one week, and (−) = no growth in four weeks of incubation. All culture samples were harvested by 14000 g centrifugation for 30-min at 4 °C after 30-days of incubation. The pellets were analyzed for IIFS using CNP surface-antigen-specific mAb 8D10, followed by Alexa Fluor 488 goat-anti-mouse IgG antibody ([@b21]). In addition, Hoechst stain was used to detect conventional bacterial contamination. As a positive control for Hoechst, *E. coli* (nonpathogenic strain HB101) was used. Fluorescence photographs were taken using an Olympus BX60F5 microscope coupled to a Nikon digital camera DXM 1200F.

SEM and EDS microanalysis
-------------------------

Papillary samples 2--4 mm in block size were analyzed both for morphology and chemical composition using JEOL 6340 Field Emission SEM with attached IXRF EDS analyzer ([@b14]). Each sample was divided into 4 equal mapping areas and scanned for small, 100--500 nm spherical apatite forms. Cultured CNP and one oxalate kidney stone sample (provided by Louis C. Herring Laboratory, Orlando, FL) were prepared for SEM analysis using the same preparation technique for tissue samples. SEM results were rated as (−)= no CNP observed; otherwise as the number of mapped areas in which CNP were seen (+ to ++++).

Biochemical assays
------------------

The commercially available ELISA kits for detecting anti-CNP IgG and CNP-antigen; Nano-Sero IgG ELISA, and Nanocapture ELISA (Nanobac Oy, Finland), respectively, were used. All measurements were run in duplicates. The detection antibody in Nanocapture recognizes CaP-binding protein-antigen on CNP in a special CaP complex conformation (ELISA kit inserts). There was not enough serum of subject \#17 for ELISA tests. ELISA results were rated as shown in [Table 1](#tbl1){ref-type="table"}.

###### 

ELISA result ratings

  Units/ml      −       \+          ++           +++            ++++
  ------------- ------- ----------- ------------ -------------- -------
  Nanocapture   \<3.5   3.5--10.9   11.0--49.9   50.0--149.90   \>150
  NanoSero      \<0.1   0.1--0.39   0.4--0.49    0.5--0.69      \>0.7

Statistical analysis
--------------------

Descriptive results of the various analytic techniques are displayed in terms of ratings in [Table 2](#tbl2){ref-type="table"}. Association between SEM findings and CNP growth ratings in tissue cultures was quantified in terms of contingency table analysis (Fisher Exact Test) with ratings collapsed to either 0 \[rating = (−)\] or 1 \[rating = (+) -- (++++)\]. A similar analysis was made for possible association between SEM and ELISA-Ag concentration ratings.

###### 

Observation of Randall's plaques on gross inspection, and the detection of CNP by various methods

  Sample no   Tissue analysis   Blood analysis                                   
  ----------- ----------------- ---------------- ------ ---- ----- ------ ------ -----
  1           −                 −                −      −    −     +++    \+     −
  2           \+                \+               +++    \+   −     +++    \+     \+
  3           \+                \+               +++    \+   ++    ++     +++    −
  4           \+                −                +++    \+   \+    \+     +++    \+
  5           \+                \+               \+     \+   ++    +++    ++     −
  6           \+                \+               +++    \+   ++    ++++   −      −
  7           −                 −                +++    \+   ++    +++    \+     −
  8           \+                \+               ++++   \+   \+    ++++   ++++   \+
  9           −                 −                ++++   \+   \+    ++++   ++++   \+
  10          −                 \+               +++    \+   ++    ++     ++     \+
  11          −                 −                ++     \+   \+    \+     −      \+
  12          \+                \+               −      −    −     \+     ++++   \+
  13          −                 −                +++    \+   −     \+     ++     \+
  14          \+                \+               \+     \+   \+    \+     ++     \+
  15          \+                \+               −      −    \+    \+     ++++   +++
  16          \+                −                ++     \+   \+    \+     ++     \+
  17          \+                −                \+     \+   +++   +++    ND     ND
  Positive    11                9                14     14   13    17     14     11

**Abbreviations:** CNP, calcifying nanoparticles; IHC, immunohistochemistry; SEM, scanning electron microscopy; EDS, energy dispersive X-ray spectroscopy; ND, not done.

**Notes:** The serum and tissue homogenate cultures for CNP have a rating of ++++: growth in one week, +++: growth in two weeks, ++: growth in three weeks, +: growth in four weeks, −: no growth in four weeks of incubation. SEM is rated as 0 if no CNP is observed, 1 if CNP are seen in one of the four mapped areas, 2 if CNP are seen two of the four mapped area, 3 if CNP are seen three of the four mapped area, and 4 if CNP are seen in every scanned area at 1500X magnification. ELISA results are rated according to the ELISA kit manufacturer's "1 unit" definition

Results
=======

Subjects
--------

Eleven male and 6 female patients were enrolled in our study, with a mean age of 66 ± 10 and 78 ± 11 years, respectively. Visually, RP were observed on the papillae of 11 patients, with no sexual preponderance. No correlation was found between the observation of RP and the patients' tumor types ([Table 3](#tbl3){ref-type="table"}). Urine cultures for conventional bacteria were negative in 12 patients, showed mild growth of genital flora in 3 patients and were positive for enterococcus species in 2 patients.

###### 

Association between the observation of Randall's plaques and the patients' tumor types

  Diagnosis                                RP +   RP −   p-value (chi-square test of diagnosis versus RP)
  ---------------------------------------- ------ ------ --------------------------------------------------
  RCC                                      4      5      0.18
  TCC                                      3      1      0.92
  Other[\*](#tf3-2){ref-type="table-fn"}   4      0      0.28

**Abbreviations:** RCC, renal cell carcinoma; TCC, transitional cell carcinoma.

**Notes:** Including oncocytoma and medullary fibroma.

IHS
---

The results of papillae analyzed using IHS is summarized in [Table 2](#tbl2){ref-type="table"}. Nine out of 17 tissue samples stained positive for CNP antigen. Positive staining results, as a brown-colored precipitate at the antigen site, are shown in [Figures 3A, B, and F](#fig3){ref-type="fig"}. Negative controls that were stained with the same technique by omitting the mAb did not show any nonspecific signal ([Figure 3E](#fig3){ref-type="fig"}). Eight papillary samples were IHS negative. ([Figures 3C, D](#fig3){ref-type="fig"}).

![Immunohistochemical (IHS) staining of paraffin-embedded renal tissue by using anti-CNP monoclonal antibody. Brown color shown by black arrows indicates positive signal (existence of CNP antigen) in the tissue. The images shown at **A** (100X) and **B** (200X) are from renal plaque-positive, IHS-positive tissue. **C** (100X) and **D** (400X) are from IHS-negative tissue, **E** and **F** (200X) are consecutive sections from a positive tissue. **E** is stained by omitting the monoclonal antibody, showing no positive signal whereas **F** positively stained in one of the collecting ducts.](ijn0301-105-03){#fig3}

CNP cultures of serum samples and tissue homogenates
----------------------------------------------------

All serum samples and 13 of 17 papillary tissue homogenates and pellets contained CNP at different growth rates ([Table 2](#tbl2){ref-type="table"}). Three serum samples were already positive within 3-days of culture. All propagation-positive samples stained positive with IIFS using anti-CNP mAb ([Figure 4A](#fig4){ref-type="fig"}), but stained negative with the Hoechst ([Figure 4B](#fig4){ref-type="fig"}), indicating no bacterial contamination in cultures. The positive control for Hoechst dye, *E. coli*, was stained blue ([Figure 4D](#fig4){ref-type="fig"}), but no nonspecific-signal was detected with 8D10 ([Figure 4C](#fig4){ref-type="fig"}). None of the samples analyzed with IIFS showed autofluorescence prior to staining. SEM of cultured CNP showed typical morphology of CNP ([Figure 5A](#fig5){ref-type="fig"}), as described earlier ([@b5]). Control cultures revealed no CNP growth, mineralization, or protein precipitation.

![Light microscopic images of double staining results of patient samples cultured under CNP culture conditions. (**A**) IIFS of cultured patient samples showed positive fluorescence signal using monoclonal antibody 8D10 when imaged with the green bandpass emission filter, (**B**) Negative results of Hoechst dye of sample A imaged with the blue bandpass emission filter. (**C**) IIFS of negative bacterial control (nonpathogenic E. coli strain HB101) showed no fluorescence signal using CNP-specific monoclonal antibody when imaged with green bandpass emission filter. (**D**) Positive results of Hoechst dye of sample C imaged with the blue bandpass emission filter.](ijn0301-105-04){#fig4}

![SEM images of (**A**): cultured CNPs from a serum sample, (**B**, **C**, and **D**): CaP spheres detected on renal papilla (Randall's plaque). Bars; 2 μm.](ijn0301-105-05){#fig5}

SEM Analysis
------------

Fourteen of 17 tissue samples contained CNP-like spheres in various sizes ([Figures 5B-D](#fig5){ref-type="fig"} and [6B](#fig6){ref-type="fig"}). Tissues with visible macroscopic plaques had more apatite spheres compared to the samples with nonvisible plaques in SEM ([Figure 7](#fig7){ref-type="fig"}). The tissue cells with those apatite particles looked more deformed with fibrous formations ([Figures 5C, D](#fig5){ref-type="fig"}, and [7F](#fig7){ref-type="fig"}) whereas the negative tissue cells appeared more intact ([Figures 6A](#fig6){ref-type="fig"} and [7G](#fig7){ref-type="fig"}). The spheres produced an EDS pattern ([Figure 6C](#fig6){ref-type="fig"}) identical to the CNP EDS patterns as observed in earlier studies ([@b14]; [@b7]).

![SEM analysis of renal papilla and EDS analysis. **A**, Renal cells with no plaques. **B**, renal cells with plaque formations showing bumpy surface. White arrows show the spherical apatite formations on renal cells. **C**, EDS analysis of the one representative apatite sphere on the cells shown in **B**.](ijn0301-105-06){#fig6}

![Images from Randall's plaques. (**A**) Tiny calcifications at the tip of the renal papilla. (**B**) Relatively large calcified plaques. (**C**) A cross section through the renal papilla, showing sub-epithelial calcifications running deep into the renal medulla (approximately 3 mm). Images of renal papillary tissue with (**D**) and without (**E**) visible plaque formations. and their SEM images (**F**) and (**G**), respectively. Black arrows show streaks of plaques in the tissue, white small arrows show the apatite spheres on the tissue. Bars in **F** and **G** are 10 μm.](ijn0301-105-07){#fig7}

In SEM analysis, oxalate kidney stone had spherical units in the core, similar to cultured CNP from renal plaques ([Figure 2](#fig2){ref-type="fig"}) with identical EDS patterns.

ELISA
-----

Out of 16 tested serum samples, 14 were positive for CNP-antigen, and 11 were positive for CNP-antibody. ELISA results are summarized at [Table 4](#tbl4){ref-type="table"}. Serum samples collected before and after surgery had no statistical difference showing that the measured biomarkers can be reproducibly measured. The mean antigen values before and after surgery were 184.294 ± 273.606 Units/ml and 180.103 ± 275.644 Units/ml respectively. The mean antibody values before and after surgery were 0.169 ± 0.136 Units/ml and 0.150 ± 0.148 Units/ml respectively.

###### 

Summary of ELISA results

  Units/ml      −      \+      ++     +++    ++++
  ------------- ------ ------- ------ ------ ------
  Nanocapture   2/16   2/16    5/16   3/16   4/16
  NanoSero      5/16   10/16   1/16   0/16   0/16

Association between CNP and SEM detection of RP
-----------------------------------------------

Two-by-two contingency tables for SEM (detection of spherical apatite formations on renal papilla) versus tissue culture growth and SEM versus ELISA-Ag concentration ratings are shown in [Tables 5](#tbl5){ref-type="table"} and [6](#tbl6){ref-type="table"}, respectively. Note that 12 of 14 positive SEM samples showed CNP growth, while 1 of 3 negative samples showed growth ([Table 5](#tbl5){ref-type="table"}, p = 0.121, Fisher's Exact Test). On the other hand the ELISA-Ag results were preponderantly positive regardless of the SEM results ([Table 6](#tbl6){ref-type="table"}, p = 0.650, Fisher's Exact Test).

###### 

Fisher's exact analysis of SEM/EDS test results versus CNP propagation from the papillary tissue results

  SEM/EDS     CNP propagation from the tissue homogenate   Total   
  ----------- -------------------------------------------- ------- ----
  **0**       2                                            1       3
  **1**       2                                            12      14
  **Total**   4                                            13      17

**Notes:** Fisher's exact= 0.121; 1-sided Fisher's exact= 0.121.

###### 

Fisher's exact analysis of SEM/EDS test results versus ELISA-Ag test results

  SEM/EDS     ELISA-Ag results   Total   
  ----------- ------------------ ------- ----
  **0**       0                  3       3
  **1**       2                  11      13
  **Total**   2                  14      16

**Notes:** Fisher's exact= 1.000; 1-sided Fisher's exact= 0.650.

Discussion
==========

Plaques, defined as sites of interstitial crystal deposition at or near the papillary tip, are found in kidneys of CaOx-stone formers (100%) and often, but less frequently (43%), in people who do not form CaOx stones ([@b18]). The nucleus of these plaques are composed of CaP ([@b9]). Despite extensive studies on RP, the etiology of the initial CaP accumulation remains elusive.

The detection of CNP in human urinary stones ([@b7]; [@b27]) inspired the hypothesis that CNP might be the initiating agents in the formation of RP and subsequently renal stones. CNP resemble the snowballs (\~0.1--0.5 μm) from pathological calcifications described by Merck Manual. In addition, they cause rapid *in situ* precipitation of CaP from blood and other body fluids under conditions not normally conducive to such precipitation ([@b14]). CNP are renotropic, as reported from rabbit experiments using injected radiolabelled-CNP and are eliminated from the circulation through urinary excretion ([@b1]). It was also shown that translumbar, percutaneous, intrarenal injection of CNP into rats resulted in renal stone formation ([@b10]). Whether CNP themselves serve as the nucleus for crystal formation by simply lowering the activation barrier or they induce calcification by some other mechanism under much lower supersaturation conditions is yet to be determined.

In this study, we investigated the presence of CNP in the RP of non stone-forming patients. For apparent reasons, kidneys could not be obtained from healthy subjects to serve as negative controls. Similarly, kidneys from renal stone patients are normally not removed, unless complicated by severe hydronephrosis or superimposed pyelonephritis. All subjects in our study had their kidneys removed due to a renal mass.

We observed RP in 65% of the kidneys, and searched for CNP in the renal papillae through IHS, SEM, and culture techniques. 72% of plaque-positive tissues were positive for CNP antigen in IHS whereas 83% of plaque-negative tissues were negative, indicating a statistically significant association (p = 0.043). Negative IHS in plaque-positive samples could happen if the section plane does not pass through the plaque. On the other hand, a plaque-negative sample may stain positive if CNP antigen is present in the tissue but macroscopically undetectable.

SEM of papillae revealed CNP-like spheres in the majority of samples, irrespective of the presence of visible RP ([Figure 5](#fig5){ref-type="fig"}). As with IHS, CNP morphology may not be observed in a plaque-positive tissue if the SEM section plane does not include the plaque. Similarly, CNP may be detected in a plaque-negative sample in the early stages of plaque development. This is in agreement with the hypothesis that all large renal stones begin as small calculi and large RP begin as minuscule calcifications. This may explain some of our CNP detection in plaque-negative samples. In EDS analysis, only the CNP-like spheres on papillae produced calcium and phosphate peaks identical to that of CNP in previous reports.

In our earlier TEM analysis of CNP shells, we described their morphology as "tree-age-ring-like" formations of crystal and organic matter ([@b15]), a description which is almost identical to observations in RP ([Figure 1](#fig1){ref-type="fig"}) by others ([@b9]). We also have observed apatite spherical-formations in the core of kidney stones independent of their overall chemical composition ([Figure 2](#fig2){ref-type="fig"}), and cultured CNP from those stones ([@b7]).

To see if these apatite spheres are actually capable of propagating, we cultured the papillary tissue extracts obtained from our patients. Thirteen of 17 samples grew CNP within 4 weeks ([Table 2](#tbl2){ref-type="table"}), which were identified by IIFS of harvested culture pellets with the CNP-specific mAb. We cultured patient sera obtained before and after surgery, all of which turned positive within 4-weeks ([Table 3](#tbl3){ref-type="table"}). The differences observed in the propagation rate may reflect existence of CNP in different concentrations. ELISA tests measuring CNP antigen (14/16) and antibody (11/16) in sera also strongly correlate with culture results.

To a great extent, our studies accord with and confirm much of Randall's pioneering work. The plaque is interstitial and composed of apatite. What we add here is that many of the apatite formations can propagate in cultures and are stainable with CNP-specific mAb. Therefore one conclusion could be that RP contain CNP. Where do these CNP come from? [@b29] suggested a vascular origin for RP. We have detected CNP in blood ([@b14]). CNP may form foci or agglomerate in kidneys when excreted in the urine and ultimately may develop into RP ([@b15]). CaP spheres 200 nm in size have been observed in many pathological calcifications ([@b3]) including atherosclerotic and RP. Interestingly, CNP have been detected in similar calcifications ([@b22]). CNP could be the elusive CaP snowballs found in pathological calcifications.

Conclusion
==========

There is a correlation between RP and the presence of CNP. If supported by further work, the establishment of CNP as the etiology of RP will direct a fundamentally novel treatment approach for urinary stone disease. If so, inhibiting the propagation of CNP ([@b4]) would make urinary stone prevention a conceivable possibility.
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